Related Experiment Video
Updated: Mar 11, 2026

Author Spotlight: Advancing Allergic Rhinitis Research with Multicolor Immunofluorescence
Published on: September 22, 2023
Olfaction in patients with allergic rhinitis: an indicator of successful MP-AzeFlu therapy
Ludger Klimek1, Sophia C Poletti2, Annette Sperl1
1Zentrum für Rhinologie und Allergologie, Wiesbaden, Germany.
Background:
The purpose of this study was to investigate the effect of MP-AzeFlu on olfaction and the interaction between severity of allergic rhinitis and olfactory improvement after therapy.
Methods:
A prospective, multicenter, observational study was performed on 47 patients with persistent allergic rhinitis. Duration and severity of allergic rhinitis was diagnosed and classified using the modified Allergic Rhinitis and its Impact on Asthma (ARIA) criteria and the proof of allergen sensitization from positive skin-prick tests, specific immonoglobulin E (IgE) in serum, and nasal provocation response. Patients were treated with MP-AzeFlu (1 spray/nostril twice daily) over 3 months. Olfactory function was assessed at baseline and at 1 and 3 months of therapy using the "Sniffin' Sticks" test. In addition, a nasal symptom score was recorded on a visual analog scale (VAS) at each given time-point.
Results:
MP-AzeFlu was found to be associated with a significant improvement in TDI score, from 23.7 at baseline to 34.2 at 1 month (p < 0.001) and 37.1 at 3 months (p < 0.001) of treatment. Furthermore, a highly significant improvement of symptoms over time (p < 0.001; VAS at baseline: 84.3; 1 month: 32.4; 3 months: 26.2) could be demonstrated. Most importantly, there was a highly significant interaction between the severity of allergic rhinitis and olfactory function (p < 0.001) and VAS (p < 0.001).
Conclusion:
MP-AzeFlu is associated with olfactory improvement in persistent allergic rhinitis patients. Further, the modified ARIA severity classification is an indicator of patients' olfactory function. Moreover, assessment of olfaction seems to be a reliable indicator of the clinical success of antiallergic/antiinflammatory therapy.
Insights
MP-AzeFlu significantly improved olfaction and reduced nasal symptoms in allergic rhinitis patients. Severity of allergic rhinitis impacts olfactory function, suggesting olfaction assessment can gauge treatment success.
Area of Science:
- Allergy and Immunology
- Rhinology
- Neuroscience
Background:
- Persistent allergic rhinitis often impairs olfaction.
- The relationship between allergic rhinitis severity and olfactory function requires further investigation.
Purpose of the Study:
- To evaluate the impact of MP-AzeFlu on olfactory function in patients with persistent allergic rhinitis.
- To explore the interaction between allergic rhinitis severity and olfactory improvement following MP-AzeFlu therapy.
Main Methods:
- Prospective, multicenter observational study involving 47 patients with persistent allergic rhinitis.
- Olfactory function assessed using the "Sniffin' Sticks" test at baseline and after 1 and 3 months of MP-AzeFlu treatment.
- Allergic rhinitis severity classified using modified ARIA criteria; nasal symptoms recorded via VAS.
Main Results:
- MP-AzeFlu treatment led to significant improvements in TDI scores (23.7 to 37.1) and VAS scores (84.3 to 26.2) over 3 months (p < 0.001).
- A significant interaction was observed between allergic rhinitis severity and both olfactory function (p < 0.001) and VAS scores (p < 0.001).
Conclusions:
- MP-AzeFlu is associated with significant olfactory improvement in patients with persistent allergic rhinitis.
- Modified ARIA severity classification effectively indicates patients' olfactory function.
- Olfactory assessment serves as a reliable measure of clinical success for antiallergic/anti-inflammatory therapies.
Related Concept Videos
Olfactory Receptors: Location and Structure
Olfaction
The olfactory receptors are embedded in the cilia of the...
Physiology of Smell and Olfactory Pathway
The olfactory...
Drugs Used in Upper Respiratory Disorders: Overview
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
Assessment of Respiration
Subjective Assessment: Nurses interview the patient to gather information directly during the subjective assessment. It includes questions about the individual's medical history, medications, and symptoms, focusing on past respiratory conditions like...
Respiratory System Abnormal Finding II: Palpation and Auscultation
Palpation Findings
During a respiratory assessment, palpation can reveal several vital abnormalities:

